Remote Jobs at Pulmovant
Find your next remote opportunity · 1 Open Position
Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases.
Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH).
Mosliciguat is a novel, potential first-in-class, sGC activator with a differentiated mechanism that may have broad applicability across the PH spectrum.
12hr
Director, Biostatistics
Director of Biostatistics leading statistical strategy for Pulmovant’s Phase 3 PH-ILD trial. Driving regulatory-ready analyses for its inhaled mosliciguat treatment.
Google Cloud Platform
12hr
No more jobs available.